Adherence of Primary Care Physicians to Evidence-Based Recommendations to Reduce Ovarian Cancer Mortality
- PMID: 26978124
- PMCID: PMC5289707
- DOI: 10.1089/jwh.2015.5735
Adherence of Primary Care Physicians to Evidence-Based Recommendations to Reduce Ovarian Cancer Mortality
Abstract
Ovarian cancer is the deadliest gynecologic cancer. Receipt of treatment from a gynecologic oncologist is an evidence-based recommendation to reduce mortality from the disease. We examined knowledge and application of this evidence-based recommendation in primary care physicians as part of CDC gynecologic cancer awareness campaign efforts and discussed results in the context of CDC National Comprehensive Cancer Control Program (NCCCP). We analyzed primary care physician responses to questions about how often they refer patients diagnosed with ovarian cancer to gynecologic oncologists, and reasons for lack of referral. We also analyzed these physicians' knowledge of tests to help determine whether a gynecologic oncologist is needed for a planned surgery. The survey response rate was 52.2%. A total of 84% of primary care physicians (87% of family/general practitioners, 81% of internists and obstetrician/gynecologists) said they always referred patients to gynecologic oncologists for treatment. Common reasons for not always referring were patient preference or lack of gynecologic oncologists in the practice area. A total of 23% of primary care physicians had heard of the OVA1 test, which helps to determine whether gynecologic oncologist referral is needed. Although referral rates reported here are high, it is not clear whether ovarian cancer patients are actually seeing gynecologic oncologists for care. The NCCCP is undertaking several efforts to assist with this, including education of the recommendation among women and providers and assistance with treatment summaries and patient navigation toward appropriate treatment. Expansion of these efforts to all populations may help improve adherence to recommendations and reduce ovarian cancer mortality.
Conflict of interest statement
Author Disclosure Statements No competing financial interests exist.
Figures




Similar articles
-
Potential Strategies to Increase Gynecologic Oncologist Treatment for Ovarian Cancer.J Womens Health (Larchmt). 2021 Jun;30(6):769-781. doi: 10.1089/jwh.2021.0178. J Womens Health (Larchmt). 2021. PMID: 34128688 Free PMC article. Review.
-
Involvement of gynecologic oncologists in the treatment of patients with a suspicious ovarian mass.Obstet Gynecol. 2011 Oct;118(4):854-62. doi: 10.1097/AOG.0b013e31822dabc6. Obstet Gynecol. 2011. PMID: 21934449
-
Risk-reducing Bilateral Salpingo-oophorectomy: Assessing the Incidence of Occult Ovarian Cancer and Surgeon Adherence to Recommended Practices.J Minim Invasive Gynecol. 2020 Nov-Dec;27(7):1511-1515. doi: 10.1016/j.jmig.2020.01.004. Epub 2020 Jan 9. J Minim Invasive Gynecol. 2020. PMID: 31927044
-
Differences in referral patterns based on race for women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic.Gynecol Oncol. 2019 Aug;154(2):379-382. doi: 10.1016/j.ygyno.2019.05.031. Epub 2019 Jun 10. Gynecol Oncol. 2019. PMID: 31196574 Free PMC article.
-
The Impact of Bias and Stigma on Patient Referral for Metabolic/Bariatric Surgery: An Algerian Experience.Obes Surg. 2025 Jun;35(6):2342-2351. doi: 10.1007/s11695-025-07882-w. Epub 2025 Apr 23. Obes Surg. 2025. PMID: 40268839 Review.
Cited by
-
Patient and Provider Perspectives on Barriers to Accessing Gynecologic Oncologists for Ovarian Cancer Surgical Care.Womens Health Rep (New Rochelle). 2020 Dec 28;1(1):574-583. doi: 10.1089/whr.2020.0090. eCollection 2020. Womens Health Rep (New Rochelle). 2020. PMID: 35982990 Free PMC article.
-
Potential Strategies to Increase Gynecologic Oncologist Treatment for Ovarian Cancer.J Womens Health (Larchmt). 2021 Jun;30(6):769-781. doi: 10.1089/jwh.2021.0178. J Womens Health (Larchmt). 2021. PMID: 34128688 Free PMC article. Review.
-
Association of Distance to Gynecologic Oncologist and Survival in a Rural Midwestern State.Womens Health Rep (New Rochelle). 2022 Aug 4;3(1):678-685. doi: 10.1089/whr.2022.0016. eCollection 2022. Womens Health Rep (New Rochelle). 2022. PMID: 36147832 Free PMC article.
-
Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.Cancer. 2017 Dec 15;123 Suppl 24(Suppl 24):5138-5159. doi: 10.1002/cncr.31027. Cancer. 2017. PMID: 29205312 Free PMC article.
-
Rural disparities in surgical care from gynecologic oncologists among Midwestern ovarian cancer patients.Gynecol Oncol. 2021 Feb;160(2):477-484. doi: 10.1016/j.ygyno.2020.11.006. Epub 2020 Nov 18. Gynecol Oncol. 2021. PMID: 33218682 Free PMC article.
References
-
- U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2012 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2015. [accessed on December 1, 2015]. Available at: www.cdc.gov/uscs.
-
- Stewart SL, Rim SH, Richards TB. Gynecologic oncologists and ovarian cancer treatment: Avenues for improved survival. J Womens Health (Larchmt) 2011;20:1257–1260. - PubMed
-
- Cress RD, Bauer K, O’Malley CD, et al. Surgical staging of early stage epithelial ovarian cancer: Results from the CDC-NPCR ovarian patterns of care study. Gynecol Oncol. 2011;121:94–99. - PubMed
-
- Chan JK, Sherman AE, Kapp DS, et al. Influence of gynecologic oncologists on the survival of patients with endometrial cancer. J Clin Oncol. 2011;29:832–838. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical